Tarnate, Renerose .

HRN: 28-15-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2025
METRONIDAZOLE 500MG (TAB)
11/24/2025
12/01/2025
PO
500 Mg
TID
Thickly MSAF S/P NSVD With RMLE
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines